Safety Study of Vemuafenib, an Oral Inhibitor of BRAFV60

Project: Research project

Project Details

Description

Safety Study of Vemuafenib, an Oral Inhibitor of BRAFV600E in Children with Recurrent/Refractory BRAFV600E-mutant astrocytomas
StatusFinished
Effective start/end date1/1/1812/31/18

Funding

  • UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.